PE27999A1 - Forma de dosificacion farmaceutica que enmascara el sabor y que se libera rapidamente - Google Patents
Forma de dosificacion farmaceutica que enmascara el sabor y que se libera rapidamenteInfo
- Publication number
- PE27999A1 PE27999A1 PE1997001188A PE00118897A PE27999A1 PE 27999 A1 PE27999 A1 PE 27999A1 PE 1997001188 A PE1997001188 A PE 1997001188A PE 00118897 A PE00118897 A PE 00118897A PE 27999 A1 PE27999 A1 PE 27999A1
- Authority
- PE
- Peru
- Prior art keywords
- weight
- nucleus
- layer
- coating
- polymer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Abstract
CARACTERIZADO PORQUE COMPRENDE: UN NUCLEO, QUE CONTIENE DE 0,1% A 73,5% EN PESO DE PRINCIPIO ACTIVO, DE 0,5% A 34% EN PESO DE HIDROXIPROPILCELULOSA Y DE 26% A 99,4% EN PESO DE CELULOSA MICROCRISTALINA; UNA CAPA DE UN RECUBRIMIENTO INTERIOR, FORMADA SOBRE EL NUCLEO, QUE CONTIENE DESDE UN 70% EN PESO DE UN POLIMERO SOLUBLE EN AGUA, COMO HIDROXIPROPILMETILCELULOSA (HIPROMELOSA) o HIDROXIPROPILCELULOSA Y HASTA UN 30% EN PESO DE UN POLIMERO INSOLUBLE EN AGUA COMO ETILCELULOSA, COPOLIMERO DE METACRILATO o COPOLIMERO DE METACRILATO DE AMINOALQUILO; UNA CAPA DE UN RECUBRIMIENTO EXTERIOR, FORMADA SOBRE EL RECUBRIMIENTO INTERIOR, QUE CONTIENE DESDE UN 70% EN PESO DE UN POLIMERO INSOLUBLE EN SALIVA, COMO POLI(DIETILAMINOACETATO DE VINILACETAL) o COPOLIMERO DE METACRILATO DE BUTILO/METACRILATO DE 2-DIMETILAMINOETILO/METACRILATO DE METILO Y HASTA UN 30% EN PESO DE UN POLIMERO SOLUBLE O INSOLUBLE EN AGUA; Y OPCIONALMENTE, UNA CAPA DE UN RECUBRIMIENTO DE AZUCAR. TAMBIEN SE REFIERE AL PROCEDIMIENTO DE PREPARACION DE LAS PARTICULAS DEL NUCLEO, QUE COMPRENDE SOMETER LOS MATERIALES MEZCLADOS A UNA GRANULACION POR AGITACION EN HUMEDO, UN TRATAMIENTO DE SECADO Y LUEGO DE TAMIZADO. ESTA FORMULACION TIENE PROPIEDADES MEJORADAS DE LIBERACION DEL FARMACO Y DE ENMASCARAMIENTO DEL SABOR DE MAS DE 50 SEGUNDOS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB9700003 | 1997-01-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE27999A1 true PE27999A1 (es) | 1999-03-12 |
Family
ID=11004515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1997001188A PE27999A1 (es) | 1997-01-06 | 1997-12-30 | Forma de dosificacion farmaceutica que enmascara el sabor y que se libera rapidamente |
Country Status (36)
| Country | Link |
|---|---|
| EP (1) | EP0941075B1 (es) |
| JP (1) | JP3350059B2 (es) |
| KR (1) | KR20000069899A (es) |
| CN (1) | CN1244119A (es) |
| AP (1) | AP802A (es) |
| AR (1) | AR008553A1 (es) |
| AT (1) | ATE238776T1 (es) |
| AU (1) | AU715867B2 (es) |
| BG (1) | BG103541A (es) |
| BR (1) | BR9714253A (es) |
| CA (1) | CA2277017C (es) |
| CO (1) | CO4650099A1 (es) |
| DE (1) | DE69721559T2 (es) |
| DK (1) | DK0941075T3 (es) |
| EA (1) | EA199900521A1 (es) |
| ES (1) | ES2192265T3 (es) |
| HN (1) | HN1997000151A (es) |
| HR (1) | HRP980005A2 (es) |
| HU (1) | HUP0002744A3 (es) |
| ID (1) | ID21806A (es) |
| IL (1) | IL130582A0 (es) |
| IS (1) | IS5095A (es) |
| MA (1) | MA26464A1 (es) |
| NO (1) | NO993315D0 (es) |
| NZ (1) | NZ336251A (es) |
| OA (1) | OA11072A (es) |
| PA (1) | PA8443301A1 (es) |
| PE (1) | PE27999A1 (es) |
| PL (1) | PL334439A1 (es) |
| SK (1) | SK89599A3 (es) |
| TN (1) | TNSN98002A1 (es) |
| TR (1) | TR199901564T2 (es) |
| UY (1) | UY24835A1 (es) |
| WO (1) | WO1998030209A1 (es) |
| YU (1) | YU31599A (es) |
| ZA (1) | ZA9829B (es) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6200591B1 (en) | 1998-06-25 | 2001-03-13 | Anwar A. Hussain | Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction |
| DE19834506A1 (de) * | 1998-07-31 | 2000-02-03 | Hexal Ag | Transmucosales therapeutisches System zur Anwendung von Sildenafil |
| DE19834507A1 (de) * | 1998-07-31 | 2000-02-03 | Hexal Ag | Pharmazeutische, wasserlösliche Tablettenformulierung zur Anwendung von Sildenafil |
| UA67802C2 (uk) * | 1998-10-23 | 2004-07-15 | Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. | Фармацевтична композиція з контрольованим вивільненням інгібітора цгмф фде-5 (варіанти), спосіб її одержання та спосіб лікування еректильної дисфункції |
| EP1133282A4 (en) * | 1998-11-25 | 2006-03-29 | Cima Labs Inc | TASTE-MAKING DELIVERY SYSTEM WITH FAST RELEASE |
| FR2795962B1 (fr) * | 1999-07-08 | 2003-05-09 | Prographarm Laboratoires | Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif |
| US7501409B2 (en) | 2000-09-06 | 2009-03-10 | Mitsubishi Tanabe Pharma Corporation | Preparations for oral administration |
| GB0102342D0 (en) * | 2001-01-30 | 2001-03-14 | Smithkline Beecham Plc | Pharmaceutical formulation |
| AR034813A1 (es) * | 2001-07-20 | 2004-03-17 | Novartis Ag | Composiciones farmaceuticas y uso de las mismas |
| SE0202365D0 (sv) * | 2002-08-05 | 2002-08-05 | Pharmacia Ab | New formulation and use thereof |
| US8039482B2 (en) | 2004-03-25 | 2011-10-18 | Astellas Pharma Inc. | Composition of solifenacin or salt thereof for use in solid formulation |
| BG66010B1 (bg) * | 2004-12-08 | 2010-10-29 | "Софарма" Ад | Лекарствена форма на силденафил |
| EP2098225B8 (en) * | 2005-01-06 | 2011-06-22 | Cima Labs Inc. | Taste masking system for non-plasticizing drugs |
| US7815939B2 (en) | 2005-07-20 | 2010-10-19 | Astellas Pharma Inc. | Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms |
| JPWO2007010930A1 (ja) * | 2005-07-20 | 2009-01-29 | アステラス製薬株式会社 | 口腔内崩壊製剤用の薬物含有被覆微粒子及びその製造方法 |
| JP2007031407A (ja) | 2005-07-29 | 2007-02-08 | Shin Etsu Chem Co Ltd | 低置換度セルロースエーテル含有コーティング用組成物及び不快な味が隠蔽されたフィルムコーティング製剤 |
| US20070098746A1 (en) * | 2005-11-02 | 2007-05-03 | Nichols William M | Multi-layered coating technology for taste masking |
| JP4602949B2 (ja) * | 2006-08-02 | 2010-12-22 | 和光堂株式会社 | 被覆粒子含有組成物及びその製造方法 |
| JPWO2008059881A1 (ja) * | 2006-11-14 | 2010-03-04 | サンスター株式会社 | 水溶性物質で表面処理された結晶セルロースを含む口腔用組成物 |
| JP5777273B2 (ja) * | 2008-07-10 | 2015-09-09 | 大正製薬株式会社 | 不快な呈味を有する薬物を含有する製剤粒子 |
| US20100136110A1 (en) * | 2008-09-30 | 2010-06-03 | Astellas Pharma Inc. | Granular pharmaceutical composition for oral administration |
| WO2010067140A1 (es) | 2008-12-12 | 2010-06-17 | Siegfried Rhein S.A. De C.V. | Composicion de liberacion pulsatil de sildenafil y proceso para prepararla |
| DE102009016584A1 (de) | 2009-04-06 | 2010-10-07 | Ratiopharm Gmbh | Schmelztablette, enthaltend ein Sildenafil-Salz |
| EP2524689B1 (en) * | 2009-12-28 | 2016-10-05 | Nipro Corporation | Method for producing donepezil tablets |
| JP5226732B2 (ja) * | 2010-05-20 | 2013-07-03 | エスエス製薬株式会社 | 催眠用圧縮成型製剤 |
| TWI462739B (zh) * | 2010-11-02 | 2014-12-01 | Univ Kaohsiung Medical | Ｓｉｌｄｅｎａｆｉｌ－同族物四級銨哌嗪鹽類之製備及醫療用途 |
| GB201119985D0 (en) * | 2011-11-19 | 2012-01-04 | Diurnal Ltd | Treatment of adrenal insufficiency |
| CN103271940B (zh) * | 2013-05-03 | 2014-03-12 | 湖北新济药业有限公司 | 复方金属离子补充剂及其制备方法 |
| WO2017146052A1 (ja) * | 2016-02-23 | 2017-08-31 | ニプロ株式会社 | 医薬組成物粒子とそれを含む口腔内崩壊製剤、医薬組成物粒子の製造方法 |
| EP3845219A4 (en) * | 2018-08-28 | 2022-06-08 | Towa Pharmaceutical Co., Ltd. | ACTIVE PARTICLE |
| CN113559070B (zh) * | 2021-08-18 | 2022-12-06 | 广州中冠动物药业有限公司 | 一种适用于宠物咳嗽的药物制备方法 |
| CN116139088B (zh) * | 2023-01-31 | 2024-04-16 | 南京海纳医药科技股份有限公司 | 一种含有枸橼酸西地那非的干混悬剂及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63258809A (ja) * | 1987-04-16 | 1988-10-26 | Towa Yakuhin Kk | 医薬活性成分の放出性にすぐれ、かつ苦味を隠蔽した細粒剤 |
| EP0458751A1 (en) * | 1990-05-25 | 1991-11-27 | Warner-Lambert Company | Delivery system for cyclic amino acids with improved taste, texture and compressibility |
| JP2576927B2 (ja) * | 1992-05-15 | 1997-01-29 | ファイザー製薬株式会社 | 細粒核 |
| JP3350054B2 (ja) * | 1994-07-08 | 2002-11-25 | アストラゼネカ・アクチエボラーグ | 複数単位の錠剤化された剤形▲ｉ▼ |
-
1997
- 1997-11-20 AU AU48808/97A patent/AU715867B2/en not_active Ceased
- 1997-11-20 ID IDW990633A patent/ID21806A/id unknown
- 1997-11-20 PL PL97334439A patent/PL334439A1/xx unknown
- 1997-11-20 HU HU0002744A patent/HUP0002744A3/hu unknown
- 1997-11-20 SK SK895-99A patent/SK89599A3/sk unknown
- 1997-11-20 NZ NZ336251A patent/NZ336251A/xx unknown
- 1997-11-20 BR BR9714253-0A patent/BR9714253A/pt not_active Application Discontinuation
- 1997-11-20 TR TR1999/01564T patent/TR199901564T2/xx unknown
- 1997-11-20 JP JP53068398A patent/JP3350059B2/ja not_active Expired - Fee Related
- 1997-11-20 WO PCT/IB1997/001471 patent/WO1998030209A1/en active IP Right Grant
- 1997-11-20 EA EA199900521A patent/EA199900521A1/ru unknown
- 1997-11-20 ES ES97911402T patent/ES2192265T3/es not_active Expired - Lifetime
- 1997-11-20 YU YU31599A patent/YU31599A/sh unknown
- 1997-11-20 CN CN97181252A patent/CN1244119A/zh active Pending
- 1997-11-20 IL IL13058297A patent/IL130582A0/xx unknown
- 1997-11-20 AT AT97911402T patent/ATE238776T1/de not_active IP Right Cessation
- 1997-11-20 EP EP97911402A patent/EP0941075B1/en not_active Expired - Lifetime
- 1997-11-20 DK DK97911402T patent/DK0941075T3/da active
- 1997-11-20 KR KR1019997006093A patent/KR20000069899A/ko not_active Application Discontinuation
- 1997-11-20 DE DE69721559T patent/DE69721559T2/de not_active Expired - Fee Related
- 1997-11-20 CA CA002277017A patent/CA2277017C/en not_active Expired - Lifetime
- 1997-11-21 HN HN1997000151A patent/HN1997000151A/es unknown
- 1997-12-18 CO CO97073877A patent/CO4650099A1/es unknown
- 1997-12-19 PA PA19978443301A patent/PA8443301A1/es unknown
- 1997-12-30 PE PE1997001188A patent/PE27999A1/es not_active Application Discontinuation
-
1998
- 1998-01-02 UY UY24835A patent/UY24835A1/es unknown
- 1998-01-05 TN TNTNSN98002A patent/TNSN98002A1/fr unknown
- 1998-01-05 HR HRPCT/IB97/00003A patent/HRP980005A2/hr not_active Application Discontinuation
- 1998-01-05 AR ARP980100030A patent/AR008553A1/es not_active Application Discontinuation
- 1998-01-05 MA MA24919A patent/MA26464A1/fr unknown
- 1998-01-05 ZA ZA9829A patent/ZA9829B/xx unknown
- 1998-01-06 AP APAP/P/1998/001173A patent/AP802A/en active
-
1999
- 1999-06-25 IS IS5095A patent/IS5095A/is unknown
- 1999-06-30 BG BG103541A patent/BG103541A/xx unknown
- 1999-07-02 OA OA9900150A patent/OA11072A/en unknown
- 1999-07-05 NO NO993315A patent/NO993315D0/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE27999A1 (es) | Forma de dosificacion farmaceutica que enmascara el sabor y que se libera rapidamente | |
| CR6656A (es) | Forma de dosificacion de farmacos accionada por un hidrogel | |
| TNSN01123A1 (fr) | Formes posologiques nouvelles a liberation controlee | |
| ES2301575T5 (es) | Forma de dosificación farmacéutica con múltiples recubrimientos | |
| BR9808888A (pt) | Formas de dosagem e método de melhorar disfunção erétil masculina | |
| AR045076A1 (es) | Composicion de pelicula que se disuelve oralmente, pelicula multicomponente que se disuelve oralmente, uso de la composicion de pelicula y de la pelicula que se disuelve oralmente para preparar un medicamento, forma de dosificacion oral y procedimiento para preparar la composicion de pelicula que se | |
| MD20070267A (en) | Gastroresistant pharmaceutical formulation containing rifaximin | |
| CA2415643A1 (en) | Pharmaceutical composition for oral use with improved absorption | |
| ES2178268T3 (es) | Formulaciones de liberacion controlada. | |
| RS20070511A (en) | Modified release pharmaceutical compositions and processes thereof | |
| PT1183014E (pt) | Composicoes farmaceuticas orais de libertacao controlada e de dissimulacao de sabor | |
| PE20071139A1 (es) | Formulacion de liberacion sostenida que comprende octreotida y dos o mas polimeros de polilactido-co-glicolido | |
| HUP0401308A2 (hu) | Folyékony polimer kompozíció szájüregi betegségek megelőzésére és kezelésére | |
| CO5560533A2 (es) | Preparacion de una composicion farmaceutica de liberacion sostenida | |
| Mishra et al. | Development and evaluation of mucoadhesive buccal patches of flurbiprofen | |
| ECSP066267A (es) | Composiciones de liberacion controlada de betahistina | |
| BRPI0502411A (pt) | processo de desenvolvimento de substáncias como inibidores potentes e seletivos de isoformas de fosfodiesterases dos tipos 1 a 5 (pde1,pde2,pde3, pde4, pde5) na base de diocleìna, fluranol ou análogos e suas composições farmacêuticas para o estudo e tratamento de doenças cardiovasculares e produtos associados | |
| SE9603480D0 (sv) | Beredningsform för svårlösliga läkemedel | |
| PT96921B (pt) | Dispositivo de libertacao intermitente | |
| Saravanan et al. | Hydroxypropyl methylcellulose based cephalexin extended release tablets: Influence of tablet formulation, hardness and storage on in vitro release kinetics | |
| Gajbhiye et al. | Formulation and evaluation of transdermal patches of benidipine hydrochloride | |
| ATE424191T1 (de) | Ph-unabhängige pharmazeutische formulierungen mit verlängerter freisetzung | |
| BRPI0415725A (pt) | formulação aspergìvel transdérmica, método para administrar um agente farmaceuticamente ativo e método para formar uma pelìcula farmaceuticamente ativa | |
| AR045576A1 (es) | Composicion farmaceutica que comprende drospirenona y etinilestradiol | |
| BRPI0408805A (pt) | composição farmacêutica contendo complexo de platina e método de fabricação da mesma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |